BridgeMD
New treatment option for Hereditary Pancreatic Cancer
Official title Increasing Germline Genetic Testing for Patients With Cancer
ClinicalTrials.gov ID: NCT07307664
What this study is testing
- What it's testing
- Germline testing for hereditary cancer syndromes is underutilized across most health care settings. Using a learning health care approach, the Genomics-enabled Learning Health Systems (gLHS) network aims to evaluate the impact of a suite of implementation strategies to increase germline test ordering by oncology care teams (i.e., mainstreaming) for eligible patients with breast, pancreatic or colorectal cancer.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults. Healthy volunteers may be eligible.
You may be able to join if
- Oncology care team members (including, but not limited to, oncologists, advanced practice providers, nurse navigators, caring for patients with adult...
You likely can't join if
- Providers not on the oncology care team
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
- Orlando, Florida, United States
- Decatur, Georgia, United States
- Chicago, Illinois, United States
- Indianapolis, Indiana, United States
- Durham, North Carolina, United States
- Salisbury, North Carolina, United States
- Danville, Pennsylvania, United States
- Nashville, Tennessee, United States
- Salt Lake City, Utah, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States; Orlando, Florida, United States; Decatur, Georgia, United States; Chicago, Illinois, United States; Indianapolis, Indiana, United States; Durham, North Carolina, United States and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.